Safepram 10 mg tablet 2 x 7’s
₨ 218 Original price was: ₨ 218.₨ 207Current price is: ₨ 207.
Rs. 26.55/tablet
7 tablet(s)/Strip
Pack Size: 2 x 7’s tablet
Safepram 10 mg tablet 2 x 7’s is a prescription medication primarily used to treat depression. They belong to the category of selective serotonin reuptake inhibitors (SSRIs) and work by regulating brain chemicals involved in mood control. Below is a detailed overview of Safepram Tablets, including their usage, safety precautions, side effects, and storage recommendations.
1. Requires Prescription:
Yes
2. Generic Composition:
Escitalopram as Oxalate
3. Indication:
Safepram Tablets are primarily prescribed for the treatment of depression.
How Safepram Tablets Work
Safepram Tablets belong to the SSRI group of medications. SSRIs influence the brain chemicals known as amines, which significantly control mood and emotional states. By increasing the serotonin levels in the brain, these tablets help alleviate symptoms of depression, promoting mental well-being.
Dosage and Administration
Safepram Tablets contain Escitalopram as Oxalate. The dosage must be strictly adhered to as prescribed by a healthcare professional. Self-medication or altering the prescribed dose is strongly discouraged.
Side Effects of Safepram Tablets
While Safepram Tablets are effective in managing depression, they may cause side effects in some individuals. Common side effects include:
- Gastrointestinal Issues: Nausea, dry mouth, diarrhea
- Neurological Symptoms: Sleeplessness, fatigue, drowsiness, or yawning
- Sexual Dysfunction: Decreased sexual drive, problems with ejaculation or erection, and difficulties in achieving orgasm (for women)
- Other Effects: Increased sweating, decreased appetite, or loss of appetite
If any of these symptoms persist or worsen, consult your physician promptly.
Drug Interactions
Safepram Tablets may interact with other medications, which could alter their effectiveness or increase side effects. Common drug interactions include:
- Antipsychotics: Atypical antipsychotics, phenothiazines
- Antidepressants: Tricyclics, SSRIs, and neuroleptics
- Pain Relievers: Tramadol and non-steroidal anti-inflammatory drugs (NSAIDs)
- Other Interactions: Lithium, tryptophan, omeprazole, fluvoxamine, and certain beta-blockers (e.g., metoprolol)
Always inform your healthcare provider about any other medications or supplements you are taking to avoid harmful interactions.
Precautions and Warnings
Precautions:
- Patients with panic disorder may experience an initial increase in anxiety during treatment. Starting with a low dose is recommended to minimize this effect.
- Regular monitoring is essential for individuals with a history of epilepsy, mania, or hypomania.
Warnings:
- Seizures: Safepram should be discontinued if seizures occur for the first time or if seizure frequency increases.
- Diabetes: Safepram can impact glycemic control. Adjustments to insulin or oral hypoglycemic drugs may be required.
- Manic Episodes: SSRIs should be stopped in patients entering a manic phase.
When Not to Use Safepram Tablets
Avoid using Safepram Tablets if you:
- Are allergic to escitalopram, citalopram, or any of its ingredients?
- Have unstable epilepsy or uncontrolled seizures.
Storage Instructions
Safepram Tablets should be stored at room temperature, away from direct sunlight and heat. Ensure the medication is kept out of reach of children.
Pregnancy and Lactation
Safepram Tablets fall under a pregnancy category that necessitates consultation with a healthcare provider before use. This ensures the safety of both the mother and the fetus.
Final Thoughts on Safepram Tablets
Safepram Tablets are a reliable solution for managing depression and improving mental health. However, they must be used under strict medical supervision due to potential side effects and interactions. Adhering to the prescribed dosage and following safety guidelines can help achieve the best therapeutic outcomes.
For any concerns regarding Safepram Tablets, always seek advice from your healthcare provider.

Reviews
There are no reviews yet.